P
Pharmala Biotech Holdings Inc
CNSX:MDMA
Pharmala Biotech Holdings Inc
CNSX:MDMA
Price:
0.16
CAD
-3.03%
Market Cap:
CA$17.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
P
|
Pharmala Biotech Holdings Inc
CNSX:MDMA
|
CA |
|
Electreon Wireless Ltd
OTC:ELWSF
|
IL |
|
WASGAU Produktions & Handels AG
F:MSH
|
DE |
|
W
|
Workspace Group PLC
F:WRX1
|
UK |
|
E
|
Edip Gayrimenkul Yatirim Sanayi ve Ticaret AS
IST:EDIP.E
|
TR |
|
F
|
Flight Centre Travel Group Ltd
F:FLI
|
AU |
|
T
|
Thai Airways International PCL
SET:THAI
|
TH |
|
L
|
Lloyds Banking Group PLC
F:LLD2
|
UK |
|
M
|
Marie Brizard Wine and Spirits SA
DUS:BED
|
FR |
|
Robinhood Markets Inc
NASDAQ:HOOD
|
US |
|
Endesa SA
OTC:ELEZY
|
ES |
|
M
|
Mfe-Mediaforeurope NV
MIL:MFEB
|
IT |
|
B
|
Banco Bradesco SA
F:BREC
|
BR |
|
L
|
Lloyds Banking Group PLC
XMUN:LLD
|
UK |
|
W
|
Willdan Group, Inc
F:J2A
|
US |
Intrinsic Value
Not Available for MDMA
There is not enough data to reliably calculate the intrinsic value for Pharmala Biotech Holdings Inc.
Do our valuations actually work? See backtest results .
Alternatives to MDMA
Fundamental Analysis
What Pharmala Biotech Does
PharmAla Biotech Holdings is a Canadian drug-development company focused on MDMA and related psychedelic compounds. It does not sell a consumer medicine business; instead, it works in the regulated supply chain for research and future medical use. The company’s core job is to make these substances under controlled standards and help move them through the approvals process.
- Headquarters
- Canada CA
- IPO date
- Jan 11, 2022
Financials
Efficiency
Earnings Waterfall
Pharmala Biotech Holdings Inc
Pharmala Biotech Holdings Inc
